These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35720036)

  • 1. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors.
    Chen HY; Zhou YL; Chen YH; Wang X; Zhang H; Ke NW; Liu XB; Tan CL
    World J Gastroenterol; 2020 Jul; 26(25):3638-3649. PubMed ID: 32742132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
    Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
    Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms.
    Lu Z; Li T; Liu C; Zheng Y; Song J
    J Endocrinol Invest; 2023 May; 46(5):927-937. PubMed ID: 36394822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms.
    Zhou H; Zhu Y; Qin B; Liu Y; Wang Z; Guo C; Wang J; Chen X
    Endocrine; 2024 Nov; 86(2):584-591. PubMed ID: 38844608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
    Primavesi F; Klieser E; Cardini B; Marsoner K; Fröschl U; Thalhammer S; Fischer I; Hauer A; Urbas R; Kiesslich T; Neureiter D; Zitt M; Klug R; Wundsam H; Sellner F; Karner J; Függer R; Cakar-Beck F; Kornprat P; Öfner D; Stättner S;
    Eur J Surg Oncol; 2019 Feb; 45(2):198-206. PubMed ID: 30262324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
    Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
    Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study.
    Guo N; Liang Z; Xiong LJ
    Medicine (Baltimore); 2022 Oct; 101(41):e31019. PubMed ID: 36254020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
    Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection.
    Milione M; Maisonneuve P; Pellegrinelli A; Spaggiari P; Centonze G; Coppa J; Delconte G; Droz Dit Busset M; Lanhazo O; Pruneri G; Mazzaferro V
    Eur J Surg Oncol; 2019 May; 45(5):755-760. PubMed ID: 30366875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    World J Surg; 2019 Jan; 43(1):175-182. PubMed ID: 30097704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
    Hijioka S; Yamashige D; Esaki M; Honda G; Higuchi R; Masui T; Shimizu Y; Ohtsuka M; Kumamoto Y; Katanuma A; Gotohda N; Akita H; Unno M; Endo I; Yokoyama Y; Yamada S; Matsumoto I; Ohtsuka T; Hirano S; Yasuda H; Kawai M; Aoki T; Nakamura M; Hashimoto D; Rikiyama T; Horiguchi A; Fujii T; Mizuno S; Hanada K; Tani M; Hatori T; Ito T; Okuno M; Kagawa S; Tajima H; Ishii T; Sugimoto M; Onoe S; Takami H; Takada R; Miura T; Kurita Y; Kamei K; Mataki Y; Okazaki K; Takeyama Y; Yamaue H; Satoi S;
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1416-1426.e5. PubMed ID: 38615727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on surgical treatment of pancreatic neuroendocrine neoplasms.
    D'Haese JG; Tosolini C; Ceyhan GO; Kong B; Esposito I; Michalski CW; Kleeff J
    World J Gastroenterol; 2014 Oct; 20(38):13893-8. PubMed ID: 25320524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study.
    Pan M; Yang Y; Teng T; Lu F; Chen Y; Huang H
    BMC Gastroenterol; 2021 Mar; 21(1):101. PubMed ID: 33663420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.